Skip to main content
Free EU delivery over €110.00Ships to all 27 EU + 3 EEA countriesSealed manufacturer packs · plain packagingNow accepting Credit & Debit cards
New: pay by Credit or Debit card — we email you a secure payment link.

Active ingredient

Modafinil

What is modafinil?

Modafinil is a wakefulness-promoting medicine that is prescription-only in the EU/EEA. Since a 2010 EMA review, its EU use is restricted to adults with excessive sleepiness caused by narcolepsy; it should no longer be used for sleep apnoea, shift-work sleep disorder or idiopathic hypersomnia. Headache is its most common side effect.

Reviewed by the Kam4eu editorial team on 13 August 2026 · Next review August 2027

2 generic Modafinil products — same molecule, different brands, formats and pack sizes.

What modafinil is used for

  • Excessive sleepiness associated with narcolepsy, with or without cataplexy, in adults.
  • No longer for obstructive sleep apnoea, shift-work sleep disorder or idiopathic hypersomnia: the EMA found the evidence of benefit did not outweigh the risks.
  • Not for children or adolescents under 18.

Source: EMA — Modafinil referral

Why modafinil's EU use is limited to narcolepsy

  • The EMA's 2010 review found modafinil's effectiveness shown in narcolepsy, but the trial data in other sleep disorders did not provide strong evidence of benefit.
  • It also linked modafinil to serious, life-threatening skin reactions (with a higher risk in children), to psychiatric reactions such as suicidal thoughts, depression and psychosis, and to raised blood pressure and irregular heartbeat.
  • Modafinil is not a replacement for sleep: the EU product information says good sleep habits should be kept, including reviewing caffeine intake.
  • Zopiclone, in the same range, does the opposite job — a short-term sleeping tablet for insomnia — and the two are not interchangeable.

Safety essentials

  • Not for people with uncontrolled moderate-to-severe high blood pressure or heart-rhythm problems; an ECG is recommended before starting, with blood pressure and heart rate monitored during treatment.
  • Serious rash, including Stevens-Johnson syndrome, toxic epidermal necrolysis and DRESS, has been reported, mostly 1 to 5 weeks after starting: stop at the first sign of rash and do not restart.
  • New or worsening psychiatric symptoms — anxiety, depression, suicidal thoughts, psychosis, mania or aggression — mean stop and see a doctor. In an emergency call 112.
  • Should not be used during pregnancy (the EU product information was updated after a 2019 EMA PRAC review of possible birth defects); women who could become pregnant need effective contraception during treatment and for two months after stopping. It should not be used while breastfeeding.

Source: EMA — Modafinil Article 31 referral (2010): product information annexes I–IV

Interactions

  • Hormonal contraceptives: may be less effective — use alternative or additional contraception during treatment and for two months after stopping.
  • Warfarin: its clearance may fall; prothrombin time should be monitored during the first 2 months and after dose changes.
  • Phenytoin: its clearance may fall — watch for signs of toxicity.
  • Carbamazepine and phenobarbital may lower modafinil levels.
  • Ciclosporin, HIV protease inhibitors, triazolam, midazolam and most calcium-channel blockers and statins: their levels may be reduced.
  • Some tricyclic and SSRI antidepressants: lower doses may be needed in people who lack the CYP2D6 enzyme.

Source: EMA — Modafinil Article 31 referral (2010): product information annexes I–IV

How it works

Modafinil acts on the central nervous system to promote wakefulness and reduce excessive daytime sleepiness. Its exact mechanism is not fully understood, but it is thought to influence several chemical messengers in the brain involved in regulating the sleep-wake cycle, including dopamine. It helps you stay awake but does not replace a proper night's sleep.

How it is taken

Take modafinil exactly as prescribed and follow the patient information leaflet. The EU product information says the daily dose is taken either once in the morning or split between the morning and noon, and that treatment is started by, or under the supervision of, a doctor with appropriate knowledge of narcolepsy. To avoid difficulty sleeping, do not take it late in the day, and keep good sleep habits: modafinil is not a replacement for sleep.

Modafinil side effects

The EU product information names headache as the most common side effect, affecting about 21% of patients — usually mild or moderate, dose-dependent and gone within a few days. Common (1 to 10 in 100): decreased appetite; nervousness, insomnia, anxiety, depression and confusion; dizziness, sleepiness and pins and needles; blurred vision; a fast heartbeat or palpitations; stomach pain, nausea, dry mouth, diarrhoea, indigestion and constipation; weakness and chest pain.

Source: EMA — Modafinil Article 31 referral (2010): product information annexes I–IV

Common (usually mild and temporary):

  • Headache
  • Difficulty sleeping (insomnia), especially if taken late in the day
  • Nausea or other stomach upset
  • Nervousness, anxiety or feeling jittery
  • Dizziness
  • Dry mouth

Stop and seek medical help if you experience:

  • A serious skin or hypersensitivity reaction (rash, blistering, peeling skin, mouth sores or facial swelling) — stop taking it and seek urgent medical attention
  • Chest pain, or a fast, pounding or irregular heartbeat
  • New or worsening mental-health symptoms such as anxiety, depression, hallucinations, agitation or thoughts of self-harm
  • Signs of a severe allergic reaction, including difficulty breathing or swelling of the throat
  • Yellowing of the skin or eyes, or other signs of liver problems

Safety & who should not take it

  • Modafinil can reduce the effectiveness of hormonal contraception (pill, patch, implant and some intrauterine systems); use an additional or alternative non-hormonal method during treatment and for up to two months after stopping.
  • Must not be used with uncontrolled moderate-to-severe high blood pressure or heart-rhythm problems; the EU product information recommends an ECG before starting and regular blood-pressure and heart-rate checks during treatment.
  • Stop taking modafinil and seek urgent medical help if you develop a rash or any signs of a skin or allergic reaction, which can rarely be serious.
  • Tell your doctor about all other medicines, as modafinil interacts with many drugs, including some for blood pressure, mood, epilepsy and blood clotting.
  • Avoid or limit caffeine and other stimulants, which may add to nervousness, a fast heartbeat and difficulty sleeping.
  • Tell your doctor about any history of mental-health problems, liver or kidney disease, or alcohol or drug misuse before starting.
  • Not for anyone under 18. Should not be used during pregnancy (the EU product information was updated after a 2019 EMA PRAC review of possible birth defects); women who could become pregnant need effective contraception during treatment and for two months after stopping. Should not be used while breastfeeding.

Storage

Store in the original packaging at room temperature, below 25°C, away from moisture and direct light, out of the sight and reach of children. Return unused tablets to a pharmacy for safe disposal.

Frequently asked questions

What is modafinil prescribed for in the EU?+

Only excessive sleepiness caused by narcolepsy in adults. After reviewing the evidence, the EMA's committee concluded in November 2010 that the benefits outweigh the risks only in narcolepsy, and the European Commission's decision followed in January 2011. Doctors should no longer use it for obstructive sleep apnoea, shift-work sleep disorder or idiopathic hypersomnia.

What are the side effects of modafinil?+

Headache is the most common, affecting about 21% of patients in clinical trials and usually mild and short-lived. Common ones include nervousness, insomnia, anxiety, dizziness, decreased appetite, nausea, dry mouth, a fast heartbeat and chest pain. Less common but serious: severe skin reactions, psychiatric reactions and raised blood pressure — stop and get medical help; in an emergency call 112.

Does modafinil interact with other medicines?+

Yes. The EU product information warns that it can make hormonal contraceptives less effective (use other methods during treatment and for two months after), may slow the clearance of warfarin and phenytoin, and may lower the levels of ciclosporin and of medicines such as midazolam, triazolam and some statins and calcium-channel blockers. Tell your doctor about everything you take.

Does modafinil affect the contraceptive pill?+

Yes. Modafinil can reduce the effectiveness of hormonal contraceptives, increasing the risk of unintended pregnancy. Use an additional or alternative non-hormonal method during treatment and for up to two months after stopping, and discuss this with your doctor.

Will modafinil replace the need for sleep?+

No. It reduces excessive sleepiness and promotes wakefulness but does not remove your body's need for sleep or treat the underlying cause of tiredness. Continue any other treatment your doctor has recommended.

Why might modafinil keep me awake at night?+

Because it promotes wakefulness, taking it too late in the day can make it hard to fall asleep. It is usually taken in the morning to lower this risk. If insomnia is a problem, speak to your doctor rather than changing the timing yourself.

Important: This information is general and not a substitute for medical advice. Always read the patient information leaflet supplied with your medicine and consult a doctor or pharmacist before use — especially if you have existing health conditions or take other medication.

Sources

Modafinil health guides

Order on WhatsAppOrder on Telegram